Therapeutic potential of deglycosylated antibodies.
作者信息
Crispin Max
机构信息
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom.
出版信息
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10059-60. doi: 10.1073/pnas.1307776110. Epub 2013 Jun 7.
Abstract
摘要
相似文献
1
Therapeutic potential of deglycosylated antibodies.去糖基化抗体的治疗潜力。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10059-60. doi: 10.1073/pnas.1307776110. Epub 2013 Jun 7.
2
Dominant suppression of inflammation by glycan-hydrolyzed IgG.糖基水解 IgG 对炎症的优势抑制。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10252-7. doi: 10.1073/pnas.1301480110. Epub 2013 May 13.
3
Osteoimmunology: IgG immune complexes directly regulate bone homeostasis.骨免疫学：IgG免疫复合物直接调节骨稳态。
Nat Rev Rheumatol. 2015 May;11(5):257. doi: 10.1038/nrrheum.2015.51. Epub 2015 Apr 14.
4
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.阐明 IgG-Fc 价态与 FcγR 激活之间的相互作用，以设计免疫复合物抑制剂。
Sci Transl Med. 2016 Nov 16;8(365):365ra158. doi: 10.1126/scitranslmed.aaf9418.
5
Suppression of mouse IgE response by immune complexes.免疫复合物对小鼠IgE反应的抑制作用。
J Allergy Clin Immunol. 1990 Oct;86(4 Pt 1):496-502.
6
Uveitis and arthritis: experimental models and clinical correlates.葡萄膜炎与关节炎：实验模型及临床关联
Semin Arthritis Rheum. 1982 May;11(4):383-9. doi: 10.1016/0049-0172(82)90025-7.
7
Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.免疫复合物引发小鼠补体替代途径取决于IgG抗体中的N-聚糖。
Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.
8
Oral tolerance as a protective mechanism against hypersensitivity disease.口服耐受作为一种针对超敏反应性疾病的保护机制。
Monogr Allergy. 1988;24:244-50.
9
IgG Immune Complexes Break Immune Tolerance of Human Microglia.IgG 免疫复合物打破人类小神经胶质细胞的免疫耐受。
J Immunol. 2020 Nov 1;205(9):2511-2518. doi: 10.4049/jimmunol.2000130. Epub 2020 Sep 23.
10
Estrogen altered oral tolerance induction in type II collagen-induced murine arthritis.雌激素改变了II型胶原诱导的小鼠关节炎中的口服耐受诱导。
Int Arch Allergy Immunol. 2004 Jan;133(1):19-28. doi: 10.1159/000075250. Epub 2003 Nov 28.
引用本文的文献
1
Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.抗体聚集：生物制药行业中的一个问题及其在AL淀粉样变性疾病中的作用。
Protein J. 2025 Feb;44(1):1-20. doi: 10.1007/s10930-024-10237-6. Epub 2024 Nov 11.
2
The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals.IgG糖基化的重要性——在分析了超过10万人之后我们学到了什么。
Immunol Rev. 2024 Nov;328(1):143-170. doi: 10.1111/imr.13407. Epub 2024 Oct 4.
3
Analysis of Biologics Molecular Descriptors towards Predictive Modelling for Protein Drug Development Using Time-Gated Raman Spectroscopy.利用时间分辨拉曼光谱分析生物制剂分子描述符以进行蛋白质药物开发的预测建模
Pharmaceutics. 2022 Aug 5;14(8):1639. doi: 10.3390/pharmaceutics14081639.
4
Solution structure of deglycosylated human IgG1 shows the role of C2 glycans in its conformation.去糖基化人 IgG1 的溶液结构显示了 C2 聚糖在其构象中的作用。
Biophys J. 2021 May 4;120(9):1814-1834. doi: 10.1016/j.bpj.2021.02.038. Epub 2021 Mar 4.
5
Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.细菌内切糖苷酶s和免疫球蛋白g的片段揭示了它们各自有助于去糖基化的亚结构域。
J Biol Chem. 2014 May 16;289(20):13876-89. doi: 10.1074/jbc.M113.532812. Epub 2014 Mar 25.
本文引用的文献
1
Dominant suppression of inflammation by glycan-hydrolyzed IgG.糖基水解 IgG 对炎症的优势抑制。
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10252-7. doi: 10.1073/pnas.1301480110. Epub 2013 May 13.
2
Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.通过去糖基化抗 HPA-1a 单克隆抗体抑制 HPA-1a 同种异体抗体介导的血小板破坏：针对胎儿同种免疫性血小板减少症的靶向治疗。
Blood. 2013 Jul 18;122(3):321-7. doi: 10.1182/blood-2012-11-468561. Epub 2013 May 3.
3
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.酶解糖基化将致病性视神经脊髓炎谱系疾病抗水通道蛋白 4 免疫球蛋白 G 转化为治疗性抗体。
Ann Neurol. 2013 Jan;73(1):77-85. doi: 10.1002/ana.23741. Epub 2012 Oct 10.
4
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.内肽酶 EndoS 水解 IgG 聚糖可抑制实验性自身免疫性脑脊髓炎。
J Neuroinflammation. 2012 Sep 3;9:209. doi: 10.1186/1742-2094-9-209.
5
Revisiting the role of glycosylation in the structure of human IgG Fc.重新审视糖基化在人 IgG Fc 结构中的作用。
ACS Chem Biol. 2012 Sep 21;7(9):1596-602. doi: 10.1021/cb300130k. Epub 2012 Jul 10.
6
Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen.酶促自身抗体糖基水解减轻针对 VII 型胶原的自身免疫。
J Autoimmun. 2012 Dec;39(4):304-14. doi: 10.1016/j.jaut.2012.04.002. Epub 2012 May 30.
7
An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.一种具有替代聚糖特异性的内切糖苷酶允许广泛的糖蛋白重塑。
J Am Chem Soc. 2012 May 16;134(19):8030-3. doi: 10.1021/ja301334b. Epub 2012 May 2.
8
Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions.血清 IgG 的选择性失活：增强单克隆抗体受体相互作用的通用策略。
J Mol Biol. 2012 Jun 29;420(1-2):1-7. doi: 10.1016/j.jmb.2012.04.002. Epub 2012 Apr 5.
9
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?内切糖苷酶S对IgG聚糖的水解可降低系统性红斑狼疮患者免疫复合物的促炎特性：一种可能的新疗法？
Arthritis Rheum. 2012 Aug;64(8):2698-706. doi: 10.1002/art.34454.
10
Sugar-free antibodies--the bacterial solution to autoimmunity?无糖抗体——细菌对自身免疫的解决办法？
Ann N Y Acad Sci. 2009 Sep;1173:664-9. doi: 10.1111/j.1749-6632.2009.04739.x.
Zotero 插件